Janssen's Nucynta celebrates 1st birthday by adding new DPN indication
This article was originally published in Scrip
Executive Summary
Johnson & Johnson unit Janssen Pharmaceuticals celebrated the one-year birthday of its chronic pain drug Nucynta ER (tapentadol) by gaining another US indication.